Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

NCT04884217 is registered in ClinicalTrials.gov with PharmaDax Inc. as lead sponsor.

NCT NCT04884217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04884217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
Lead sponsor
PharmaDax Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
May 20, 2021
Completion date
December 30, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome, keratoconjunctivitis sicca